Arrhythmias & electrophysiologySecondary analysis

Prolonged QT interval and risk of recurrent stroke in the Atrial Cardiopathy and Antithrombotic Drugs in Prevention After Cryptogenic Stroke (ARCADIA) trial

HeartPublished

  • secondary analysis
  • randomised trial (ARCADIA)
  • North America, 2018 to 2023
  • multivariable Cox proportional hazards models

Authors' conclusion

Among patients with recent cryptogenic stroke and atrial cardiopathy, QTc prolongation was associated with a reduced risk of recurrent stroke. These findings contrast with the association observed between QTc prolongation and first stroke in the general population, which may reflect the unique characteristics of this selected population. If confirmed in broader populations, these findings suggest that electrocardiographic markers such as QTc may have distinct implications for risk stratification in terms of first versus recurrent stroke.

Study context

Population
Patients with cryptogenic stroke and atrial cardiopathy randomised to apixaban versus aspirin, excluding those with missing ECG data and prolonged QRS (≥120 ms)included patients, 139 (15.8%) had a prolonged cohort-specific QTc
Participants
881 patients
Comparison
association between QTc and recurrent stroke of any type
  • prolonged QTcn = 139

Primary result

As reported in the abstract

Recurrent strokes of any type · mean of 1.8 years

patients with recurrent strokes

62

crude rate

7.0%

annualised rate

3.9% per year

Further findings

OutcomeEstimate
Recurrent stroke, by cohort-specific QTc — cohort-specific QTc · decreased risk with prolongation · after multivariable adjustmentHR 0.72 per SD (95% CI 0.54–0.95)
Recurrent stroke, by cohort-specific QTc — prolonged QTc vs normal QTc · decreased risk with prolonged QTc · after multivariable adjustmentHR 0.16 (95% CI 0.04–0.64)

Sensitivity analyses

Findings consistent across methods of QT interval correction
Accounting for the timing of baseline ECG, QRS duration, incident atrial fibrillation and the competing risk of death did not change the results

Original publication

Prolonged QT interval and risk of recurrent stroke in the Atrial Cardiopathy and Antithrombotic Drugs in Prevention After Cryptogenic Stroke (ARCADIA) trial. Heart. Published 20 February 2026. doi:10.1136/heartjnl-2025-327253

Summarised from the published abstract; every number is checked against it